#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic granulomatous disease Vernal keratoconjunctivitis Chronic myeloid leukaemia Antiphospholipid antibodies Congenital megacolon Dent's disease Alveolar rhabdomyosarcoma Mycobacterium abscessus infection Non-small cell lung cancer recurrent Synovial sarcoma recurrent HER2 gene amplification Nodal marginal zone B-cell lymphoma Graft versus host disease Cardiomyopathy Intracranial calcification More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Diagnostics Adrenocortical carcinoma – Trials in Disease Pemphigus – Basic Information Angiosarcoma metastatic – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Richter’s syndrome – Treatment Ewing’s sarcoma metastatic Alexander disease – Basic Information Advanced systemic mastocytosis – Treatment Andersen-Tawil syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Imifoplatin TORASEMIDE Imidapril Hydrochloride Oxaliplatin Ziprasidone Empagliflozin RUBIDIUM CHLORIDE Prilocaine Buparlisib Vafidemstat DESMOPRESSIN ACETATE Spiramycin Prax-628 Digoxin Ganaxolone Betamethasone Valerate Carbetocin Sodium Chloride Ph. Eur. Basimglurant Thiotepa More therapies…

    Learn about Your Condition

    Alpha-1 antitrypsin deficiency BRAF gene mutation Benign renal neoplasm Netherton's syndrome Embolism venous Neuropathy peripheral Duchenne muscular dystrophy Diabetic autonomic neuropathy Ocular myasthenia Raynaud's phenomenon MELAS syndrome Autoimmune uveitis Adenocarcinoma gastric Chondrosarcoma Dermatitis atopic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Everolimus and Exercise to Prevent Bone Loss in Healthy Postmenopausal Women

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Everolimus
    Denmark

  • Study on Eptinezumab for Migraine: Understanding How It Works and Finding Patient Response Markers for Migraine Sufferers

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Eptinezumab
    Italy

  • Study on the Effects of Methylphenidate on Brain Function in Adults with ADHD, with or without Mood Disorders, Compared to Placebo

    Recruiting

    4 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    France

  • Study on [18F]MNI-659 to Track Huntington’s Disease Progression in Symptomatic and Pre-symptomatic Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • 2-[2-[3-[4-(2-(18F)FLUORANYLETHOXY)PHENYL]-7-METHYL-4-OXOQUINAZOLIN-2-YL]ETHYL]-4-PROPAN-2-YLOXYISOINDOLE-1,3-DIONE
    France

  • A Study of Ciprofloxacin and Vancomycin Effects in Patients Carrying Antibiotic-Resistant Bacteria (ESBL and VRE)

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ciprofloxacin
    • Vancomycin
    Sweden

  • Study on the Effect of Raxtozinameran Vaccine in Reducing Type 1 Diabetes Risk in Children with High Genetic Susceptibility

    Recruiting

    3 1 1
    Investigated Drugs:
    • Raxtozinameran
    Austria Belgium Germany Italy Poland Sweden
Previous Page
1 … 190 191 192 193 194 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!